Literature DB >> 30287184

Increased age and proton pump inhibitors are associated with severe Clostridium difficile infections in children.

Tu-Hsuan Chang1, Wei-Yun Hsu2, Tzu-I Yang3, Chun-Yi Lu3, Po-Ren Hsueh4, Jong-Min Chen4, Ping-Ing Lee3, Li-Min Huang3, Luan-Yin Chang5.   

Abstract

BACKGROUND: Clostridium difficile infection (CDI) is increasing in children. We aimed to compare the clinical characteristics between CDI and colonization and to identify the risk factors for severe diseases of CDI in children.
METHOD: We retrospectively reviewed 124 children (1-18 years old) from 2011 to 2018. CDI was defined as diarrhea (≥3 loose stool in the past 24 h) with confirmed toxigenic strain. Colonization was defined as presence of C. difficile without clinical symptoms. Severe diseases included ileus, acute kidney injury, gastrointestinal bleeding or mortality. Patients younger than 1 year old and coinfections with other enteric pathogens were excluded.
RESULTS: Among 124 patients with C. difficile identified, 49 of them fulfilled CDI definition and 75 had C. difficile colonization. Children with CDI were more likely to present with watery (74% vs. 1%, p < 0.01) and mucoid stool (25% vs. 7%, p < 0.01) and occult blood in stool (67% vs. 33%, p < 0.01) than children with colonization. In CDI cases, elevated age-adjusted creatinine (18% vs. 0%, p = 0.03) and hyponatremia (134 mEq/L vs. 137 mEq/L, p = 0.04) were found. Also, they had more complicated diseases (27% vs. 0%, p < 0.01). On multivariate analysis, age older than 4 years (adjusted odds ratio: 5.83; 95% confidence interval: 1.05-32.27) and proton pump inhibitor use (PPI) (adjusted odds ratio: 7.25; 95% confidence interval: 1.07-49.07) were the independent factors for severe diseases.
CONCLUSIONS: Watery diarrhea, mucoid stool and occult blood in stool could differentiate CDI from colonization. Patients with increased age and previous PPI use were the independent risk factors for severe diseases in children.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  CDI; Pediatric; Risk factor; Severe disease

Mesh:

Substances:

Year:  2018        PMID: 30287184     DOI: 10.1016/j.jmii.2018.09.002

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  8 in total

Review 1.  Risk factors for Clostridioides difficile infection in children and adolescents with inflammatory bowel disease: a systematic review and meta-analysis.

Authors:  Sheng-Bo Fang; Yan-Qing Song; Chun-Yan Zhang; Li-Bo Wang
Journal:  World J Pediatr       Date:  2021-11-20       Impact factor: 2.764

2.  Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.

Authors:  Ching-Chi Lee; Jen-Chieh Lee; Chun-Wei Chiu; Pei-Jane Tsai; Wen-Chien Ko; Yuan-Pin Hung
Journal:  Microbiol Spectr       Date:  2021-10-20

Review 3.  A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children.

Authors:  Valeria Dipasquale; Giuseppe Cicala; Edoardo Spina; Claudio Romano
Journal:  Front Pharmacol       Date:  2022-02-10       Impact factor: 5.810

4.  Clostridium butyricum therapy for mild-moderate Clostridioides difficile infection and the impact of diabetes mellitus.

Authors:  Jen-Chieh Lee; Chun-Wei Chiu; Pei-Jane Tsai; Ching-Chi Lee; I-Hsiu Huang; Wen-Chien Ko; Yuan-Pin Hung
Journal:  Biosci Microbiota Food Health       Date:  2021-11-03

Review 5.  Application of Microbiome Management in Therapy for Clostridioides difficile Infections: From Fecal Microbiota Transplantation to Probiotics to Microbiota-Preserving Antimicrobial Agents.

Authors:  Chun-Wei Chiu; Pei-Jane Tsai; Ching-Chi Lee; Wen-Chien Ko; Yuan-Pin Hung
Journal:  Pathogens       Date:  2021-05-24

6.  Acid Suppression Use Among Infants in One Tertiary Children's Hospital in China, 2015-2018: A Retrospective Observational Study.

Authors:  Yue Zhou; Lina Xu; Haishaerjiang Wushouer; Aichen Yu; Ziyue Xu; Chaoyang Chen; Yimin Cui; Qinghong Lu; Xiaodong Guan; Luwen Shi
Journal:  Front Pediatr       Date:  2021-05-21       Impact factor: 3.418

7.  Effect of Doxycycline in Decreasing the Severity of Clostridioides difficile Infection in Mice.

Authors:  Bo-Yang Tsai; Yi-Hsin Lai; Chun-Wei Chiu; Chih-Yu Hsu; Yi-Hsuan Chen; Yueh-Lin Chen; Pei-Jane Tsai; Yuan-Pin Hung; Wen-Chien Ko
Journal:  Antibiotics (Basel)       Date:  2022-01-17

8.  The Role of Toll-Like Receptor-2 in Clostridioides difficile Infection: Evidence From a Mouse Model and Clinical Patients.

Authors:  Yi-Hsin Lai; Bo-Yang Tsai; Chih-Yu Hsu; Yi-Hsuan Chen; Po-Han Chou; Yueh-Lin Chen; Hsiao-Chieh Liu; Wen-Chien Ko; Pei-Jane Tsai; Yuan-Pin Hung
Journal:  Front Immunol       Date:  2021-07-12       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.